Study guide
9.2 Indigenous Health, Cultural Safety, and Humility
PEBC Pharmacist Evaluating Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & The Canadian Pharmacy Practice Landscape
1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway 1.2 The Canadian Healthcare System, Canada Health Act, and Drug Regulation 1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation
2 Chapter 2: Pharmaceutics & Drug Delivery Systems
2.1 Physicochemical Principles, Solubility, Ionization, and Stability 2.2 Solid Dosage Forms, Formulation Science, and Modified-Release Technologies 2.3 Liquid and Semisolid Dosage Forms, Dispersions, and Topical Delivery 2.4 Sterile Product Principles, Parenteral Delivery, and Biopharmaceuticals 2.5 Pharmaceutical Quality: GMP, Stability Testing, and Bioequivalence
3 Chapter 3: Biopharmaceutics & Clinical Pharmacokinetics
3.1 Drug Absorption, Distribution, Metabolism, and Elimination (ADME) 3.2 Bioavailability, Bioequivalence, and Biopharmaceutics Classification System (BCS) 3.3 Pharmacokinetic Modeling, Parameters, and Dosing Calculations 3.4 Therapeutic Drug Monitoring (TDM) and Clinical Application
4 Chapter 4: Pharmacology, Toxicology & Pharmacogenetics
4.1 Autonomic and Central Nervous System Pharmacology 4.2 Cardiovascular, Renal, and Endocrine Pharmacology 4.3 Clinical Toxicology, Overdose Management, and Antidotes 4.4 Biologics, Biosimilars, and Pharmacogenetics
5 Chapter 5: Pathophysiology & Clinical Assessment
5.1 Clinical Laboratory Diagnostics, Biomarkers, and Vital Signs 5.2 Cardiovascular and Respiratory Pathophysiology 5.3 Endocrine, Renal, and Gastrointestinal Pathophysiology 5.4 Neurologic, Psychiatric, and Musculoskeletal Pathophysiology 5.5 Physical Assessment and Point-of-Care Testing
6 Chapter 6: Pharmacotherapy & Minor Ailments
6.1 Cardiovascular Pharmacotherapy & Evidence-Based Guidelines 6.2 Endocrine and Metabolic Pharmacotherapy 6.3 Infectious Diseases and Antimicrobial Stewardship 6.4 Neurologic, Psychiatric, and Pain Management Therapeutics 6.5 Minor Ailment Prescribing and Nonprescription Therapy 6.6 Respiratory Pharmacotherapy: Asthma, COPD, and Inhaled Therapy 6.7 Gastrointestinal and Hepatic Pharmacotherapy 6.8 Renal, Fluid, and Electrolyte Therapeutics 6.9 Musculoskeletal and Rheumatologic Pharmacotherapy 6.10 Dermatologic, Ophthalmic, and Ear-Nose-Throat Pharmacotherapy 6.11 Hematologic, Immunologic, and Oncology Supportive Care 6.12 Women's Health, Men's Health, and Urologic Therapeutics 6.13 Nutrition, Natural Health Products, and Complementary Medicine
7 Chapter 7: Special Populations & Applied Therapeutics
7.1 Geriatric Pharmacotherapy and Deprescribing 7.2 Pediatric and Neonatal Pharmacotherapy 7.3 Perinatal Pharmacotherapy: Pregnancy and Lactation 7.4 Dosage Adjustments in Renal and Hepatic Impairment
8 Chapter 8: Prescription Processing, Calculations & Compounding
8.1 Prescription Processing, Verification, and Drug Therapy Problem Management 8.2 Pharmaceutical Calculations and Clinical Math 8.3 Non-Sterile Compounding and NAPRA Standards 8.4 Sterile and Hazardous Compounding under NAPRA Standards 8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation
9 Chapter 9: Health Equity, Indigenous Health & Pharmacy Bioethics
9.1 Social Determinants of Health and Health Equity 9.2 Indigenous Health, Cultural Safety, and Humility 9.3 Pharmacy Bioethics, Informed Consent, and Professional Boundaries 9.4 Health Promotion, Disease Prevention, and Public Health
10 Chapter 10: Evidence Appraisal, Safety & Practice Management
10.1 Biostatistics and Critical Appraisal of Clinical Literature 10.2 Pharmacoeconomics and Pharmacoepidemiology 10.3 Medication Safety, Incident Analysis, and Quality Improvement 10.4 Pharmacy Operations, Cold-Chain Management, and Emergency Preparedness 10.5 Drug Information and Evidence-Based Decision Making 10.6 Pharmacovigilance and Adverse Drug Reaction Reporting in Canada
11 Chapter 11: Patient Care Process, Communication & Collaborative Practice
11.1 The Patient Care Process: Assessment, Care Plans, and Follow-Up 11.2 Patient and Caregiver Communication, Education, and Health Literacy 11.3 Motivational Interviewing and Shared Decision-Making 11.4 Intra- and Interprofessional Collaborative Care
12 Chapter 12: Medication Administration, Devices & Expanded Scope
12.1 Injection and Vaccine Administration Technique 12.2 Immunization Schedules, Vaccine Selection, and Travel Health 12.3 Home Medical Devices and Device Technique Coaching 12.4 Expanded Scope: Adapting, Renewing, Initiating, and Medication Reconciliation
13 Chapter 13: Pharmacy Management, Finance & Practice Leadership
13.1 Human Resources, Leadership, and Change Management 13.2 Financial Management, Drug Plans, and Marketing 13.3 Quality Improvement, Risk Management, and Workplace Safety
9.2 Indigenous Health, Cultural Safety, and Humility
Key Takeaways Explain This Topic AI
First Nations, Inuit, and Métis represent three distinct Indigenous peoples in Canada with unique histories, cultures, languages, and constitutional rights under Section 35 of the Constitution Act, 1982.
Disparities in Indigenous health outcomes are not rooted in biological traits, but are direct consequences of colonial policies, residential schools, forced dispossession, and systemic racism.
Cultural safety is an outcome determined exclusively by the patient and recipient of care, reflecting an environment free of racism, discrimination, and power imbalances.
Under Jordan's Principle and the Inuit Child First Initiative, government departments of first contact must immediately fund required health products for Indigenous children, resolving jurisdictional disputes later.
The Non-Insured Health Benefits (NIHB) program provides 100% coverage for eligible pharmacy claims for registered First Nations and recognized Inuit without patient co-payments or balance billing.
Last updated: August 2026
9.2 Indigenous Health, Cultural Safety, and Humility
Exam Focus: The PEBC Evaluating Examination requires pharmacy practitioners to demonstrate deep knowledge of Indigenous health determinants in Canada. Candidates must understand the impacts of colonialism, the Truth and Reconciliation Commission (TRC) Calls to Action, the continuum from cultural competence to cultural safety, billing and navigation under the Non-Insured Health Benefits (NIHB) program, Jordan's Principle, and safe integration of traditional Indigenous medicines.
Historical Context, Colonialism, and Health Inequities
Under Section 35 of the Constitution Act, 1982 , the Aboriginal peoples of Canada comprise three distinct groups with unique cultural identities, governance structures, and legal rights: First Nations , Inuit , and Métis .
Disparities in health outcomes between Indigenous and non-Indigenous populations in Canada—including lower life expectancy, elevated infant mortality, and disproportionate rates of type 2 diabetes, cardiovascular disease, tuberculosis, substance use disorders, and suicide—are not caused by genetic or biological predispositions. Instead, they represent the direct, cumulative consequences of colonial policies, land dispossession, structural racism, and intergenerational trauma . +-------------------------------------------------------------------------+
- | COLONIAL DRIVERS OF INDIGENOUS HEALTH INEQUITIES |
- +-------------------------------------------------------------------------+
- | 1. The Indian Act (1876): |
- | Paternalistic federal legislation enforcing assimilation, band |
- | membership controls, and systemic loss of self-determination |
- | | |
- | v |
- | 2. Indian Residential School System (IRSS) & Sixties Scoop: |
- | Forced separation of children from families, systemic emotional, |
- | physical, and sexual abuse; cultural disruption; epigenetic trauma |
- | | |
- | v |
- | 3. Segregated "Indian Hospitals" & Medical Experimentation: |
- | Substandard racially segregated healthcare, unconsented clinical |
- | nutritional experiments, and forced sterilization of Indigenous women|
- | | |
- | v |
- | 4. Ongoing Systemic Racism in Contemporary Healthcare: |
- | Interpersonal stereotyping, neglect, and diagnostic delays |
- | (e.g., Brian Sinclair inquiry, Joyce Echaquan coroner's report) |
- +-------------------------------------------------------------------------+
- Intergenerational and Epigenetic Trauma
Intergenerational trauma refers to the transmission of trauma effects across generations following catastrophic collective experiences. The physiological stress resulting from residential schools, family separation during the Sixties Scoop, and ongoing systemic discrimination alters neuroendocrine regulatory systems (the hypothalamic-pituitary-adrenal [HPA] axis), predisposing subsequent generations to elevated cardiometabolic and psychiatric morbidity.
The Truth and Reconciliation Commission (TRC) and UNDRIP
The Truth and Reconciliation Commission of Canada (TRC) issued 94 Calls to Action in 2015 to redress the legacy of residential schools and advance national reconciliation. Calls to Action 18 through 24 specifically address health:
Call 18: Acknowledge that the current state of Indigenous health in Canada is a direct result of previous Canadian government policies, including residential schools.
Call 19: Establish measurable goals to identify and close the gaps in health outcomes between Indigenous and non-Indigenous communities.
Call 20: Recognize, respect, and address the distinct health needs of First Nations, Inuit, and Métis, including off-reserve populations.
Call 21: Provide sustainable long-term funding for existing and new Aboriginal healing centres to address the physical, mental, emotional, and spiritual harms of residential schools.
Call 22: Recognize the value of Indigenous healing practices and use them in the treatment of Indigenous patients in collaboration with Indigenous healers and Elders.
Call 23: Increase the number of Indigenous healthcare professionals and provide cultural competency training for all healthcare professionals.
Call 24: Require medical, nursing, and healthcare professional programs to deliver mandatory curriculum on Indigenous health issues, including the history and legacy of residential schools, UNDRIP, Treaties, and Indigenous rights.
In 2021, the Canadian federal government enacted the United Nations Declaration on the Rights of Indigenous Peoples Act (UNDRIP Act), legally committing federal laws to align with UNDRIP's minimum standards for the survival, dignity, and well-being of Indigenous peoples, including rights to traditional medicines and health practices (Article 24).
The Cultural Safety and Humility Continuum
Delivering equitable healthcare to Indigenous patients requires progressing along the cultural safety continuum. Cultural competence is an important step, but it is not the endpoint of professional development. +-------------------------------------------------------------------------+
- | THE CULTURAL SAFETY CONTINUUM |
- +-------------------------------------------------------------------------+
- | CULTURAL AWARENESS |
- | - Acknowledging difference and diversity exists |
- | | |
- | v |
- | CULTURAL SENSITIVITY |
- | - Recognizing that differences must be respected without judgment |
- | | |
- | v |
- | CULTURAL COMPETENCE |
- | - Acquiring knowledge, communication skills, and clinical behaviors |
- | | |
- | v |
- | CULTURAL SAFETY (The Ultimate Practice Goal) |
- | - An environment free of racism, where the patient feels secure, |
- | respected, and heard. DEFINED EXCLUSIVELY BY THE RECIPIENT OF CARE |
- +-------------------------------------------------------------------------+
- Cultural Humility
Cultural humility is a lifelong commitment to self-reflection, self-critique, and learning. It requires healthcare providers to:
Examine their own personal and systemic biases, assumptions, and privileges.
Acknowledge and actively address the power imbalances inherent in the patient-provider dynamic.
Approach every patient encounter with openness, humility, and willingness to learn from the patient as the expert in their own lived experience.
Two-Eyed Seeing ( Etuaptmumk )
Coined by Mi'kmaq Elder Albert Marshall, Two-Eyed Seeing is the guiding principle of learning to see from one eye with the strengths of Indigenous knowledges and ways of knowing, and from the other eye with the strengths of Western sciences, and using both eyes together for the benefit of all. In pharmacy, Two-Eyed Seeing encourages integrating evidence-based pharmacotherapy alongside traditional medicines, ceremonies, and holistic healing circles without creating false hierarchies.
The Non-Insured Health Benefits (NIHB) Program
The Non-Insured Health Benefits (NIHB) program is a federally funded program administered by Indigenous Services Canada (ISC) that provides coverage to eligible First Nations and Inuit clients for specified medically necessary health goods and services not covered by provincial, territorial, or private health plans. +-------------------------------------------------------------------------+
- | NIHB PHARMACY BENEFIT SUMMARY |
- +-------------------------------------------------------------------------+
- | ELIGIBLE CLIENTS: |
- | - Registered First Nations individuals (Status under Indian Act) |
- | - Recognized Inuit beneficiaries of land claim agreements |
- | - Note: Métis are NOT covered under NIHB (unless registered Status) |
- | |
- | BENEFIT TIERS ON DRUG BENEFIT LIST (DBL): |
- | - Open Benefit: Automatically reimbursed without prior approval |
- | - Limited Use (LU): Specific clinical criteria or prescriber specialty |
- | - Prior Approval / Exception: Requires formal clinical case submission |
- | |
- | BILLING & PAYMENT RULES: |
- | - Point-of-sale electronic adjudication via Express Scripts Canada |
- | - Strictly 100% covered: ZERO copayments, deductibles, or user fees |
- | - BALANCE BILLING IS STRICTLY PROHIBITED BY NIHB PROVIDER AGREEMENT |
- +-------------------------------------------------------------------------+
- Core NIHB Operational and Dispensing Rules
Client Identification: Verified using the client's 10-digit Indian Status registration number (Treaty number) or Inuit beneficiary identification.
Payer of Last Resort vs. Provincial Coordination:
If a client has private commercial insurance (e.g., through an employer), private insurance is billed first; NIHB acts as the secondary payer of last resort for remaining balances.
However, for registered First Nations and Inuit clients, NIHB provides comprehensive primary coverage relative to provincial public drug programs (with specific provincial coordination agreements in certain jurisdictions such as BC's First Nations Health Authority [FNHA]).
Prohibition of Balance Billing:
Pharmacists participating in NIHB agree to accept the NIHB-negotiated dispensing fee and reimbursement schedule. Pharmacists are strictly prohibited from charging extra fees, co-payments, or balance-billing the patient for the difference between pharmacy retail prices and NIHB reimbursement.
Emergency Dispensing Policy:
If a client requires an urgent medication on the Limited Use or Prior Approval list outside business hours or before prior approval is processed, pharmacists can dispense an emergency supply (typically up to a 7-day supply ) to prevent treatment interruptions.
Short-Term Dispensing Policy:
For stable chronic medications, NIHB covers up to a 100-day supply to optimize convenience and reduce dispensing fee overhead. For unstable, newly initiated, or acute therapies, shorter intervals (e.g., 30-day fills) are standard.
- Jordan's Principle and the Inuit Child First Initiative
- Jordan's Principle
Jordan's Principle is a child-first, human-rights principle established in memory of Jordan River Anderson , a young First Nations child from Norway House Cree Nation in Manitoba who was born with complex medical needs. Jordan spent years needlessly hospitalized while federal and provincial governments argued over who was responsible for paying for his home care equipment; he died in the hospital at age five before the dispute was resolved. +-------------------------------------------------------------------------+
- | JORDAN'S PRINCIPLE: WORKFLOW |
- +-------------------------------------------------------------------------+
- | First Nations child (0-18 years) requires health, social, or |
- | educational product / service (e.g., specialized medical formula, |
- | non-formulary compounded medication, sensory therapy, mobility aid) |
- | | |
- | v |
- | Request submitted to Jordan's Principle Focal Point |
- | | |
- | v |
- | MANDATORY FIRST-CONTACT RULE: |
- | The government department of first contact MUST PAY FOR THE SERVICE |
- | IMMEDIATELY without delays or denials |
- | | |
- | v |
- | Intergovernmental jurisdictional disputes are resolved AFTER payment |
- +-------------------------------------------------------------------------+
Legal Scope: Applies to all First Nations children living on or off reserve.
Scope of Coverage: Encompasses all health products, pharmaceuticals, medical compounding, medical devices, educational aids, and mental health supports required to meet substantive equality.
Inuit Child First Initiative: Extends the exact same legal principle and child-first mandate to all Inuit children across Canada.
Indigenous Traditional Medicines and Culturally Safe Pharmacotherapy
Indigenous healing systems are holistic, viewing health as a dynamic balance between physical, mental, emotional, and spiritual dimensions represented within the Medicine Wheel . +-------------------------------------------------------------------------+
- | THE FOUR SACRED MEDICINES & PHARMACY |
- +-------------------------------------------------------------------------+
- | 1. TOBACCO (East): First medicine; used for prayer, giving thanks, |
- | and offering respect to Elders and healers. (Distinct from commercial|
- | recreational tobacco). |
- | |
- | 2. SWEETGRASS (South): Used for cleansing, kindness, and smudging. |
- | Contains coumarin derivatives (assess if patient uses high internal |
- | concentrations alongside anticoagulants like warfarin). |
- | |
- | 3. SAGE (West): Used for purification, spiritual protection, and tea. |
- | Contains volatile thujones; non-judgmental inquiry for safety. |
- | |
- | 4. CEDAR (North): Used for cleansing, restorative tea (rich in vitamin |
- | C), and protection. Safe integration with conventional medicines. |
- +-------------------------------------------------------------------------+
- Pharmacist Clinical Assessment of Traditional Botanicals
Non-Judgmental Clinical Inquiry: Inquire about the use of traditional teas, plant medicines, and ceremonies during medication reconciliations using open, respectful language.
Pharmacological Interactions:
Bearberry / Uva Ursi ( Arctostaphylos uva-ursi ): Contains arbutin, used historically for urinary tract health; requires an alkaline urinary pH to generate active hydroquinone (avoid combining with urinary acidifiers).
Willow Bark ( Salix spp.): Contains salicin (metabolized to salicylic acid); assess additive bleeding risks when combined with NSAIDs, aspirin, or antiplatelets.
Sweetgrass ( Hierochloe odorata ): Contains natural coumarins; monitor international normalized ratio (INR) if consumed in large medicinal quantities by patients taking warfarin.